Real-time enrollment status for this adhd clinical trial
Current Status
Unknown
Checked: September 1, 2026 at 3:52 AM UTC
| NCT Number | NCT03781765 |
| Recruiting Status | Unknown |
| Condition | ADHD |
| Phase | PHASE4 |
| Target Enrollment | 44 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | August 9, 2024 (Aug 9, 2024) |
As of September 1, 2026: Clinical trial NCT03781765 is currently unknown participants. This phase4 study for adhd is not currently accepting new participants at 1 location across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03781765 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03781765 was last updated Aug 9, 2024 (August 9, 2024). HelloStudys verifies this status automatically.